Earnings Insights · Emerson Electric (EMR) · Q4 FY2026
Emerson Electric (EMR) Q4 FY2026: Emerson Q4 FY2026 Earnings: Orders and Software Strength Support a 5% FY2027 Growth Plan
By AlgovestIQ ResearchPublished
Read Emerson Electric Co.’s results announcement (Form 8-K, filed Nov 4, 2026)
Key earnings findings
Emerson Electric (EMR) Q4 FY2026 · results discussed on the earnings call · Form 8-K filed
- Emerson Electric reported Q4 FY2026 revenue of $5.20B against the $5.11B analyst estimate, a 1.8% beat, and EPS of $1.86 against the $1.85 analyst estimate, a 0.5% beat.
- Management expects Software & Systems sales growth of 7% to 8% for FY2027, Intelligent Devices growth of 4%, and Safety & Productivity growth of 3% to 4%.
- EMR closed at $170.44 on Nov 4, 2026, up 2.4% from $166.39 on Nov 3, 2026, the last close before the results were released.
Sources: Emerson Electric Co. results announcement (SEC), the Q4 FY2026 earnings call, and AlgovestIQ reported-results and market data. All references
Did Emerson Electric beat earnings expectations?
- EPS has beaten the estimate in 4 of the most recent reported quarters.
- Revenue surprise across the last 8 reported quarters has ranged from -1.0% to 1.8%.
Reported figures against analyst estimates, compiled from AlgovestIQ data.
Emerson closed fiscal 2026 with fourth-quarter revenue of $5.2B, up 7% year over year, while GAAP EPS from continuing operations increased 24% to $1.33 and adjusted EPS rose 15% to $1.86. The quarter was supported by accelerating orders, project activity in power, LNG and semiconductor markets, and a sharp profit improvement in Software & Systems.
The central takeaway is that Emerson enters FY2027 with stronger backlog and demand momentum than its 5% sales-growth outlook might suggest. Management remains cautious because Europe and China remain weak, while a growing share of backlog is tied to longer-cycle projects that will convert over a more extended period.
Earnings Snapshot
| Metric | Reported | Change |
|---|---|---|
| Net sales | $5.2B | 7% |
| Underlying sales growth | 7% | — |
| Underlying orders growth | 14% | — |
| GAAP EPS from continuing operations | $1.33 | 24% |
| Adjusted EPS | $1.86 | 15% |
| Pretax earnings | $997M | 31% |
| Pretax margin | 19.2% | 360 bps |
| Adjusted segment EBITA | $1.5B | 13% |
| Adjusted segment EBITA margin | 29.1% | 160 bps |
| Operating cash flow | $1.1B | 6% |
| Free cash flow | $916M | 9% |
| Software & Systems sales | $1.7B | 14% |
| Intelligent Devices sales | $2.9B | 5% |
| Safety & Productivity sales | $573M | 2% |
For the full year, sales increased 5% to $19.0B, including 4% underlying growth. GAAP EPS from continuing operations rose 20% to $4.79, while adjusted EPS increased 10% to $6.59. Free cash flow rose 9% to $3.5B.
The Bigger Story
The most consequential development was the acceleration in orders relative to sales. Underlying orders increased 14% in the fourth quarter, while backlog ended the year at $8.2B, up 11% year over year. The book-to-bill ratio was 1.01, above typical seasonal patterns.
That demand was concentrated in long-cycle automation and project markets, including power, LNG, aerospace and defense, semiconductor, and life sciences. Management said its project funnel increased $600M year over year to $13B, with growth verticals accounting for $500M of the sequential increase.
The order strength provides better visibility for FY2027 and beyond, but it does not necessarily translate into an immediate acceleration in reported revenue. Management said 70% of backlog is expected to convert within the next 12 months, down from a historically consistent 75%, indicating a larger portion of the order book extends into FY2028.
That mix is constructive for long-term visibility, but it also helps explain why Emerson’s FY2027 guidance calls for about 5% sales growth despite a 14% increase in quarterly orders.
Revenue and Operating Performance
Software & Systems was the standout business in the quarter. Sales increased 14% to $1.7B, driven by 14% growth in Control Systems & Software and 15% growth in Test & Measurement. The segment benefited from power, LNG and semiconductor activity, with management also citing strong demand for its Ovation power-control business.
Test & Measurement grew 15% in the quarter, including 59% order growth in semiconductor markets. Management expects high-single-digit sales growth for the business in FY2027, assuming a strong first half followed by more moderate second-half conditions as semiconductor comparisons become more difficult. Aerospace and defense demand also remains strong, while automotive is the weakest part of the portfolio.
Intelligent Devices grew 4% on an underlying basis, better than management had expected. Final Control benefited from project deliveries in the Middle East, while growth was supported by LNG, power, upstream gas and midstream gas markets. Still, the segment continues to face a drag from Europe and China, where end-market conditions remain soft.
Safety & Productivity grew 2%, with strength in electrical products and U.S. industrial activity offset by continued weakness in Europe. The modest growth rate underscores the uneven nature of industrial demand outside Emerson’s preferred growth verticals.
Geographically, the Americas grew 9% in the quarter, including 11% growth in the U.S. Asia, Middle East and Africa increased 7%, led by 19% growth in the Middle East and Africa. Europe grew just 1%.
Growth verticals were a major differentiator. These businesses grew 25% in the fourth quarter, led by LNG growth of 68%, semiconductor growth of 43%, and power growth of 24%. Management said projects represented 37% of fourth-quarter revenue, up modestly from prior periods, while MRO accounted for 63%.
Profitability and Margins
Emerson’s earnings growth outpaced revenue growth. Pretax earnings rose to $997M from $760M, lifting pretax margin by 360 basis points to 19.2%. Adjusted segment EBITA increased to $1.5B, and the corresponding margin expanded 160 basis points to 29.1%.
Software & Systems accounted for most of the margin improvement. Its adjusted segment EBITA margin rose 490 basis points to 32.3%, helped by volume leverage, favorable mix, pricing and project execution. Control Systems & Software posted a 33.1% adjusted EBITA margin, compared with 27.0% a year earlier, while Test & Measurement reached 30.3%, up from 28.5%.
Intelligent Devices’ adjusted EBITA margin declined slightly, by 10 basis points, to 28.4%, as business mix offset the benefit of volume, pricing and cost discipline. Safety & Productivity’s margin improved 30 basis points to 22.9%.
The difference between GAAP and adjusted earnings remains meaningful. Fourth-quarter adjusted EPS of $1.86 excluded $0.34 per share of intangible-amortization expense, $0.14 of restructuring costs, $0.05 of acquisition- and divestiture-related costs, and other smaller items. Restructuring and related costs totaled $63M during the quarter and $227M for the full year.
Management said fourth-quarter margin performance also benefited from project closeouts, favorable business mix and a recovery in pricing within Control Systems & Software. Those factors helped make the fourth quarter stronger than the company had anticipated, but they may not recur evenly through FY2027.
Demand, Customers and Pricing
Underlying orders increased across all business groups, led by 18% growth in Software & Systems and 13% growth in Intelligent Devices. Control Systems & Software orders rose 20%, including 26% growth in Ovation orders.
Management highlighted several large project wins: a petrochemical project in Qatar, LNG Canada’s Phase 2 expansion in British Columbia, and a 10-year DeltaV manufacturing-execution-system subscription agreement with a global life sciences contract manufacturer. These wins support Emerson’s positioning in large automation projects, though their timing of conversion into revenue will vary.
Annual contract value in software increased 10.1% to $1.7B. Management expects roughly 10% ACV growth again in FY2027. It also expects software-contract renewal timing to become a modest tailwind next year after reducing FY2026 growth by about 70 basis points.
Pricing remained favorable in FY2026. Management said the company realized roughly 3% pricing for the year, including about 2% of normalized pricing and a contribution from tariffs. Its FY2027 plan assumes 2% price realization, with price-cost expected to remain positive despite anticipated inflation in electronics and memory components.
The main demand weaknesses remain China and Europe. China orders were negative in the fourth quarter as chemical and refining markets continued to weigh on demand. Management noted that about 40% of Emerson’s China sales are exposed to petrochemical and refining markets, where industry overcapacity has constrained new capital formation. Europe is expected to improve only modestly in FY2027, with industrial demand in Germany, France and Italy remaining soft.
What is Emerson’s guidance for Q1 and FY2027?
For fiscal Q1 2027, management expects:
| Metric | FY2027 Q1 Guidance |
|---|---|
| Net sales growth | ~5% |
| Underlying sales growth | ~5% |
| GAAP EPS | $1.19 to $1.23 |
| Adjusted EPS | $1.58 to $1.62 |
| Adjusted segment EBITA margin | ~28% |
| Share repurchases | ~$1.5B |
For the full fiscal year, management expects:
| Metric | FY2027 Guidance |
|---|---|
| Net sales growth | ~5% |
| Underlying sales growth | ~5% |
| GAAP EPS | ~$5.70 |
| Adjusted EPS | ~$7.25 |
| Adjusted segment EBITA margin | ~29% |
| Operating cash flow | $4.3B to $4.4B |
| Free cash flow | $3.8B to $3.9B |
| Share repurchases | ~$2.5B |
| Dividends | ~$1.3B |
Management expects Software & Systems sales growth of 7% to 8% for FY2027, Intelligent Devices growth of 4%, and Safety & Productivity growth of 3% to 4%. Growth verticals are expected to increase by low double digits, led by power and LNG. Life sciences is expected to grow at a high-single-digit rate, while semiconductor growth is modeled at mid-single digits because management has assumed a more cautious second half.
Management also expects adjusted segment EBITA margin to rise 80 basis points to 29%. It cited positive price-cost, cost reductions, software-renewal timing and operating leverage, partly offset by project mix, continued investment and startup costs associated with an Intelligent Devices expansion.
Balance Sheet, Cash Flow and Capital
Emerson generated $3.98B of operating cash flow in FY2026 and $3.54B of free cash flow after $443M of capital expenditures. Free-cash-flow margin expanded 60 basis points to 18.6%.
Cash and equivalents ended the fiscal year at $1.8B, up from $1.5B a year earlier. Short-term borrowings and current maturities of long-term debt were $4.7B, while long-term debt was $7.5B, down from $8.3B at the prior year-end.
The company repurchased $1.0B of shares during FY2026, retiring 7.2 million shares, and paid $1.2B in dividends. It plans to return approximately $3.8B to shareholders in FY2027 through $2.5B of share repurchases and $1.3B of dividends. Emerson also increased its quarterly dividend 7% to $0.595 per share.
Management intends to front-load $1.5B of planned share repurchases into the first quarter. It said this approach supports the FY2027 share-count assumption while preserving flexibility for smaller bolt-on acquisitions. Large-scale M&A is not part of the current capital-allocation plan.
What Investors Should Watch
1. Order conversion and backlog timing
Backlog increased 11% to $8.2B, but a larger share extends beyond the next 12 months. Investors should watch whether strong project orders begin translating into growth above management’s 5% FY2027 sales outlook.
2. Europe and China demand
Management’s outlook assumes only modest improvement in Europe and no meaningful recovery in China. Further deterioration in chemical, refining or broader European industrial markets would weigh most heavily on Intelligent Devices and other automation markets outside the growth verticals.
3. Software & Systems margin durability
Software & Systems delivered a 32.3% adjusted EBITA margin in the quarter, up 490 basis points. Sustaining margins near that level would reinforce the earnings case, while a reversal in project mix, pricing or contract timing could reduce the benefit.
4. Growth-vertical execution
Power, LNG and semiconductor markets drove a disproportionate share of fourth-quarter momentum. Investors should monitor power-control orders, LNG project awards and Test & Measurement demand to assess whether Emerson can sustain low-double-digit growth in these verticals.
5. Capital returns and bolt-on discipline
The planned $3.8B shareholder return is substantial relative to annual free cash flow. The company has retained capacity for smaller acquisitions, making the balance between repurchases, dividends and bolt-on M&A an important capital-allocation variable.
AlgovestIQ Takeaway
Emerson’s fourth quarter was stronger than the headline 7% sales growth suggests. Orders accelerated to 14%, backlog rose 11%, and Software & Systems delivered both the fastest growth and the largest margin expansion. The company also generated higher cash flow while maintaining a sizable shareholder-return plan.
The unresolved issue is the gap between order momentum and the FY2027 growth outlook. Management’s 5% sales target reflects caution on Europe and China, as well as a growing share of backlog tied to longer-cycle projects. That is a reasonable constraint, but it means investors should not assume that recent order growth will convert directly into near-term revenue acceleration.
The investment case is increasingly tied to Emerson’s ability to compound growth in power, LNG, semiconductor, life sciences and software while holding margins near current levels. The company’s FY2027 plan assumes that pricing remains favorable, project activity continues and growth verticals offset weak conventional industrial markets.
Evidence of sustained backlog conversion, continued software ACV growth near 10%, and margin expansion toward the company’s 29% adjusted segment EBITA target would strengthen that case. A more pronounced slowdown in China or Europe, weaker semiconductor demand in the second half, or project delays in the Middle East would challenge it.
How did EMR stock react?
EMR closed at $170.44 on Nov 4, 2026, up 2.4% from $166.39 on Nov 3, 2026, the last close before the results were released.
| Session | Close | Change |
|---|---|---|
| Nov 3, 2026 (before release) | $166.39 | — |
| Nov 4, 2026 | $170.44 | +2.4% |
| Nov 5, 2026 | $162.61 | -2.3% |
Closing prices from AlgovestIQ market data. A move around a report also reflects the wider market.
More from this earnings season
- PHParker Hannifin Q1 FY2027 Earnings: Organic Growth Reaccelerates as Filtration Group Expands the PortfolioNov 5, 2026
- CMICummins Q3 2026 Earnings: Record Margins as Data Center Power Demand Offsets Pickup WeaknessNov 5, 2026
- ROKRockwell Automation Q4 FY2026 Earnings: Software and Controls Drive Growth as FY2027 Outlook Calls for Further Margin ExpansionNov 5, 2026
- TTTrane Technologies Q3 2026 Earnings: Backlog Surge Supports Higher Revenue Outlook, but Margins Remain UnevenOct 29, 2026
- GEVGE Vernova Q3 2026 Earnings: Power Demand Drives Backlog, Margins and Higher GuidanceOct 28, 2026
References
- Management commentary, analyst questions and outlook discussed on the call. Source: Emerson Electric Co. Q4 FY2026 earnings call transcript, as of Nov 4, 2026.
- Reported results, segment figures and guidance from the company's results announcement. Source: Emerson Electric Co. Form 8-K, Item 2.02 (SEC EDGAR), as of Nov 4, 2026.
- Reported revenue and EPS against analyst estimates, and the reported quarterly series. Source: AlgovestIQ reported-results data, as of Nov 4, 2026.
AI-generated analysis based on company-reported earnings data and earnings-call materials. Every reported figure is checked against Emerson Electric's earnings release and call transcript before publication. Not investment advice.